世界の持続的顔面紅斑治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Persistent Facial Erythema Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4527
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、持続的顔面紅斑治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（皮膚軟化剤、抗ヒスタミン薬、抗真菌薬、抗生物質、コルチコステロイド、カルシニューリン阻害薬）、用途別市場規模（病院、外来手術センター、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・持続的顔面紅斑治療の市場動向
・企業の競争状況、市場シェア
・持続的顔面紅斑治療の種類別市場規模（皮膚軟化剤、抗ヒスタミン薬、抗真菌薬、抗生物質、コルチコステロイド、カルシニューリン阻害薬）
・持続的顔面紅斑治療の用途別市場規模（病院、外来手術センター、診療所、その他）
・持続的顔面紅斑治療の北米市場規模2016-2027（アメリカ、カナダ）
・持続的顔面紅斑治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・持続的顔面紅斑治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・持続的顔面紅斑治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・持続的顔面紅斑治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Anacor Pharmaceuticals、Astellas Pharma、Galderma、Meda Pharmaceuticals、Novartis、Pfizer、Regeneron Pharmaceuticals、Sanofi、Bausch Health）
・結論

Facial erythema is a very common reason for consulting a dermatologist.
While often a manifestation of a benign condition, in some cases facial erythema may be the first sign of a more serious disorder and specific diagnostic tests are needed to rule out these diseases.

Market Analysis and Insights: Global Persistent Facial Erythema Treatment Market
The global Persistent Facial Erythema Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Persistent Facial Erythema Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Persistent Facial Erythema Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Persistent Facial Erythema Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Persistent Facial Erythema Treatment market.

Global Persistent Facial Erythema Treatment Scope and Market Size
Persistent Facial Erythema Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Persistent Facial Erythema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Emollients
Antihistamines
Antifungal
Antibiotics
Corticosteroids
Calcineurin Inhibitors

Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Anacor Pharmaceuticals
Astellas Pharma
Galderma
Meda Pharmaceuticals
Novartis
Pfizer
Regeneron Pharmaceuticals
Sanofi
Bausch Health

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Persistent Facial Erythema Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Emollients
1.2.3 Antihistamines
1.2.4 Antifungal
1.2.5 Antibiotics
1.2.6 Corticosteroids
1.2.7 Calcineurin Inhibitors
1.3 Market by Application
1.3.1 Global Persistent Facial Erythema Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Persistent Facial Erythema Treatment Market Perspective (2016-2027)
2.2 Persistent Facial Erythema Treatment Growth Trends by Regions
2.2.1 Persistent Facial Erythema Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Persistent Facial Erythema Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Persistent Facial Erythema Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Persistent Facial Erythema Treatment Industry Dynamic
2.3.1 Persistent Facial Erythema Treatment Market Trends
2.3.2 Persistent Facial Erythema Treatment Market Drivers
2.3.3 Persistent Facial Erythema Treatment Market Challenges
2.3.4 Persistent Facial Erythema Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Persistent Facial Erythema Treatment Players by Revenue
3.1.1 Global Top Persistent Facial Erythema Treatment Players by Revenue (2016-2021)
3.1.2 Global Persistent Facial Erythema Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Persistent Facial Erythema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Persistent Facial Erythema Treatment Revenue
3.4 Global Persistent Facial Erythema Treatment Market Concentration Ratio
3.4.1 Global Persistent Facial Erythema Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Persistent Facial Erythema Treatment Revenue in 2020
3.5 Persistent Facial Erythema Treatment Key Players Head office and Area Served
3.6 Key Players Persistent Facial Erythema Treatment Product Solution and Service
3.7 Date of Enter into Persistent Facial Erythema Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Persistent Facial Erythema Treatment Breakdown Data by Type
4.1 Global Persistent Facial Erythema Treatment Historic Market Size by Type (2016-2021)
4.2 Global Persistent Facial Erythema Treatment Forecasted Market Size by Type (2022-2027)

5 Persistent Facial Erythema Treatment Breakdown Data by Application
5.1 Global Persistent Facial Erythema Treatment Historic Market Size by Application (2016-2021)
5.2 Global Persistent Facial Erythema Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Persistent Facial Erythema Treatment Market Size (2016-2027)
6.2 North America Persistent Facial Erythema Treatment Market Size by Type
6.2.1 North America Persistent Facial Erythema Treatment Market Size by Type (2016-2021)
6.2.2 North America Persistent Facial Erythema Treatment Market Size by Type (2022-2027)
6.2.3 North America Persistent Facial Erythema Treatment Market Size by Type (2016-2027)
6.3 North America Persistent Facial Erythema Treatment Market Size by Application
6.3.1 North America Persistent Facial Erythema Treatment Market Size by Application (2016-2021)
6.3.2 North America Persistent Facial Erythema Treatment Market Size by Application (2022-2027)
6.3.3 North America Persistent Facial Erythema Treatment Market Size by Application (2016-2027)
6.4 North America Persistent Facial Erythema Treatment Market Size by Country
6.4.1 North America Persistent Facial Erythema Treatment Market Size by Country (2016-2021)
6.4.2 North America Persistent Facial Erythema Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Persistent Facial Erythema Treatment Market Size (2016-2027)
7.2 Europe Persistent Facial Erythema Treatment Market Size by Type
7.2.1 Europe Persistent Facial Erythema Treatment Market Size by Type (2016-2021)
7.2.2 Europe Persistent Facial Erythema Treatment Market Size by Type (2022-2027)
7.2.3 Europe Persistent Facial Erythema Treatment Market Size by Type (2016-2027)
7.3 Europe Persistent Facial Erythema Treatment Market Size by Application
7.3.1 Europe Persistent Facial Erythema Treatment Market Size by Application (2016-2021)
7.3.2 Europe Persistent Facial Erythema Treatment Market Size by Application (2022-2027)
7.3.3 Europe Persistent Facial Erythema Treatment Market Size by Application (2016-2027)
7.4 Europe Persistent Facial Erythema Treatment Market Size by Country
7.4.1 Europe Persistent Facial Erythema Treatment Market Size by Country (2016-2021)
7.4.2 Europe Persistent Facial Erythema Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Persistent Facial Erythema Treatment Market Size (2016-2027)
8.2 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Type
8.2.1 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Application
8.3.1 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region
8.4.1 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Persistent Facial Erythema Treatment Market Size (2016-2027)
9.2 Latin America Persistent Facial Erythema Treatment Market Size by Type
9.2.1 Latin America Persistent Facial Erythema Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Persistent Facial Erythema Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Persistent Facial Erythema Treatment Market Size by Type (2016-2027)
9.3 Latin America Persistent Facial Erythema Treatment Market Size by Application
9.3.1 Latin America Persistent Facial Erythema Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Persistent Facial Erythema Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Persistent Facial Erythema Treatment Market Size by Application (2016-2027)
9.4 Latin America Persistent Facial Erythema Treatment Market Size by Country
9.4.1 Latin America Persistent Facial Erythema Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Persistent Facial Erythema Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Persistent Facial Erythema Treatment Market Size (2016-2027)
10.2 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Type
10.2.1 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Application
10.3.1 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country
10.4.1 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Anacor Pharmaceuticals
11.1.1 Anacor Pharmaceuticals Company Details
11.1.2 Anacor Pharmaceuticals Business Overview
11.1.3 Anacor Pharmaceuticals Persistent Facial Erythema Treatment Introduction
11.1.4 Anacor Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.1.5 Anacor Pharmaceuticals Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Persistent Facial Erythema Treatment Introduction
11.2.4 Astellas Pharma Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.2.5 Astellas Pharma Recent Development
11.3 Galderma
11.3.1 Galderma Company Details
11.3.2 Galderma Business Overview
11.3.3 Galderma Persistent Facial Erythema Treatment Introduction
11.3.4 Galderma Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.3.5 Galderma Recent Development
11.4 Meda Pharmaceuticals
11.4.1 Meda Pharmaceuticals Company Details
11.4.2 Meda Pharmaceuticals Business Overview
11.4.3 Meda Pharmaceuticals Persistent Facial Erythema Treatment Introduction
11.4.4 Meda Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.4.5 Meda Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Persistent Facial Erythema Treatment Introduction
11.5.4 Novartis Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Persistent Facial Erythema Treatment Introduction
11.6.4 Pfizer Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Regeneron Pharmaceuticals
11.7.1 Regeneron Pharmaceuticals Company Details
11.7.2 Regeneron Pharmaceuticals Business Overview
11.7.3 Regeneron Pharmaceuticals Persistent Facial Erythema Treatment Introduction
11.7.4 Regeneron Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.7.5 Regeneron Pharmaceuticals Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Persistent Facial Erythema Treatment Introduction
11.8.4 Sanofi Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Details
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Persistent Facial Erythema Treatment Introduction
11.9.4 Bausch Health Revenue in Persistent Facial Erythema Treatment Business (2016-2021)
11.9.5 Bausch Health Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Persistent Facial Erythema Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Emollients
Table 3. Key Players of Antihistamines
Table 4. Key Players of Antifungal
Table 5. Key Players of Antibiotics
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Calcineurin Inhibitors
Table 8. Global Persistent Facial Erythema Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Persistent Facial Erythema Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Persistent Facial Erythema Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Persistent Facial Erythema Treatment Market Share by Regions (2016-2021)
Table 12. Global Persistent Facial Erythema Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Persistent Facial Erythema Treatment Market Share by Regions (2022-2027)
Table 14. Persistent Facial Erythema Treatment Market Trends
Table 15. Persistent Facial Erythema Treatment Market Drivers
Table 16. Persistent Facial Erythema Treatment Market Challenges
Table 17. Persistent Facial Erythema Treatment Market Restraints
Table 18. Global Persistent Facial Erythema Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Persistent Facial Erythema Treatment Market Share by Players (2016-2021)
Table 20. Global Top Persistent Facial Erythema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Persistent Facial Erythema Treatment as of 2020)
Table 21. Ranking of Global Top Persistent Facial Erythema Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Persistent Facial Erythema Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Persistent Facial Erythema Treatment Product Solution and Service
Table 25. Date of Enter into Persistent Facial Erythema Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Persistent Facial Erythema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Persistent Facial Erythema Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Persistent Facial Erythema Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Persistent Facial Erythema Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Persistent Facial Erythema Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Persistent Facial Erythema Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Persistent Facial Erythema Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Persistent Facial Erythema Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Persistent Facial Erythema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Persistent Facial Erythema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Persistent Facial Erythema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Persistent Facial Erythema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Persistent Facial Erythema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Persistent Facial Erythema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Persistent Facial Erythema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Persistent Facial Erythema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Persistent Facial Erythema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Persistent Facial Erythema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Persistent Facial Erythema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Persistent Facial Erythema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Persistent Facial Erythema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Persistent Facial Erythema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Persistent Facial Erythema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Persistent Facial Erythema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Persistent Facial Erythema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Persistent Facial Erythema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Persistent Facial Erythema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Persistent Facial Erythema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Persistent Facial Erythema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Persistent Facial Erythema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Persistent Facial Erythema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Persistent Facial Erythema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Persistent Facial Erythema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Persistent Facial Erythema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Anacor Pharmaceuticals Company Details
Table 66. Anacor Pharmaceuticals Business Overview
Table 67. Anacor Pharmaceuticals Persistent Facial Erythema Treatment Product
Table 68. Anacor Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 69. Anacor Pharmaceuticals Recent Development
Table 70. Astellas Pharma Company Details
Table 71. Astellas Pharma Business Overview
Table 72. Astellas Pharma Persistent Facial Erythema Treatment Product
Table 73. Astellas Pharma Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 74. Astellas Pharma Recent Development
Table 75. Galderma Company Details
Table 76. Galderma Business Overview
Table 77. Galderma Persistent Facial Erythema Treatment Product
Table 78. Galderma Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 79. Galderma Recent Development
Table 80. Meda Pharmaceuticals Company Details
Table 81. Meda Pharmaceuticals Business Overview
Table 82. Meda Pharmaceuticals Persistent Facial Erythema Treatment Product
Table 83. Meda Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 84. Meda Pharmaceuticals Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Persistent Facial Erythema Treatment Product
Table 88. Novartis Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Persistent Facial Erythema Treatment Product
Table 93. Pfizer Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 94. Pfizer Recent Development
Table 95. Regeneron Pharmaceuticals Company Details
Table 96. Regeneron Pharmaceuticals Business Overview
Table 97. Regeneron Pharmaceuticals Persistent Facial Erythema Treatment Product
Table 98. Regeneron Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 99. Regeneron Pharmaceuticals Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Bausch Health Company Details
Table 105. Bausch Health Business Overview
Table 106. Bausch Health Persistent Facial Erythema Treatment Product
Table 107. Bausch Health Revenue in Persistent Facial Erythema Treatment Business (2016-2021) & (US$ Million)
Table 108. Bausch Health Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Persistent Facial Erythema Treatment Market Share by Type: 2020 VS 2027
Figure 2. Emollients Features
Figure 3. Antihistamines Features
Figure 4. Antifungal Features
Figure 5. Antibiotics Features
Figure 6. Corticosteroids Features
Figure 7. Calcineurin Inhibitors Features
Figure 8. Global Persistent Facial Erythema Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Persistent Facial Erythema Treatment Report Years Considered
Figure 14. Global Persistent Facial Erythema Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Persistent Facial Erythema Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Persistent Facial Erythema Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Persistent Facial Erythema Treatment Market Share by Regions (2022-2027)
Figure 18. Global Persistent Facial Erythema Treatment Market Share by Players in 2020
Figure 19. Global Top Persistent Facial Erythema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Persistent Facial Erythema Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Persistent Facial Erythema Treatment Revenue in 2020
Figure 21. Global Persistent Facial Erythema Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Persistent Facial Erythema Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Persistent Facial Erythema Treatment Market Share by Type (2016-2027)
Figure 25. North America Persistent Facial Erythema Treatment Market Share by Application (2016-2027)
Figure 26. North America Persistent Facial Erythema Treatment Market Share by Country (2016-2027)
Figure 27. United States Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Persistent Facial Erythema Treatment Market Share by Type (2016-2027)
Figure 31. Europe Persistent Facial Erythema Treatment Market Share by Application (2016-2027)
Figure 32. Europe Persistent Facial Erythema Treatment Market Share by Country (2016-2027)
Figure 33. Germany Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Persistent Facial Erythema Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Persistent Facial Erythema Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Persistent Facial Erythema Treatment Market Share by Region (2016-2027)
Figure 43. China Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Persistent Facial Erythema Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Persistent Facial Erythema Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Persistent Facial Erythema Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Persistent Facial Erythema Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Persistent Facial Erythema Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Persistent Facial Erythema Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Persistent Facial Erythema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Anacor Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 63. Astellas Pharma Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 64. Galderma Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 65. Meda Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 68. Regeneron Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 70. Bausch Health Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の顔面紅斑療法市場規模・現状・予測（2021年-2027年）

Global Facial Erythema Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z2301 2021年4月 91Pages
QYResearch社発行の本調査資料では、顔面紅斑療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド...

世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1271 2021年4月 94Pages
QYResearch社発行の本調査資料では、化学療法薬誘発性肢端紅斑（手足症候群）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、抗炎症剤・抗浮腫剤、抗ヒスタミン剤、NSAID、経口/局所グルココルチコイド、ピリドキシン（ビタミンB...

世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年）

世界の顔面神経麻痺治療市場規模・現状・予測（2021年-2027年）

Global Facial Paralysis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2305 2021年4月 98Pages
QYResearch社発行の本調査資料では、顔面神経麻痺治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、理学療法）、用途別市場規模（病院、クリニック、研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のフェイシャルリンクルトリートメント市場規模・現状・予測（2021年-2027年）

Global Facial Wrinkle Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2308 2021年4月 90Pages
QYResearch社発行の本調査資料では、フェイシャルリンクルトリートメントのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非侵襲的治療、低侵襲的治療）、用途別市場規模（病院薬局、小売薬局、大型スーパーマーケット、スーパーマーケット、Eコマー...

世界の顔若返り市場規模・現状・予測（2021年-2027年）

Global Facial Rejuvenation Market Size, Status and Forecast 2021-2027
QYR2104Z2307 2021年4月 95Pages
QYResearch社発行の本調査資料では、顔若返りのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所用製品、ボツリヌス菌、皮膚充填剤、ケミカルピーリング、その他）、用途別市場規模（病院、皮膚科クリニック）、主要地域別市場規模（北米、アメリカ...

世界の顔若返り市場規模・現状・予測（2021年-2027年）

世界の3D顔認識システム市場規模・現状・予測（2021年-2027年）

Global 3D Facial Recognition Systems Market Size, Status and Forecast 2021-2027
QYR2104Z6129 2021年4月 93Pages
QYResearch社発行の本調査資料では、3D顔認識システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア、ソフトウェア）、用途別市場規模（アクセス制御、出席追跡＆モニタリング、法執行機関、その他）、主要地域別市場規模（北米、ア...

世界の顔面脂肪移植市場規模・現状・予測（2021年-2027年）

Global Facial Fat Transfer Market Size, Status and Forecast 2021-2027
QYR2104Z2303 2021年4月 93Pages
QYResearch社発行の本調査資料では、顔面脂肪移植のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（脂肪注射、皮膚充填剤、その他）、用途別市場規模（マイクロプラスチック・化粧品、アンチエイジング、その他）、主要地域別市場規模（北米、アメリカ...

世界の脂質障害治療市場規模・現状・予測（2021年-2027年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3432 2021年4月 98Pages
QYResearch社発行の本調査資料では、脂質障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他）、用途別市場規模（病院、クリニック、その他）、主要...

世界の顔面紅斑療法市場規模・現状・予測（2021年-2027年） Drugs for Facial Erythema Market Analysis and Insights: Global Facial Erythema Therapies Market The global Facial Erythema Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…
世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…
世界の顔面神経麻痺治療市場規模・現状・予測（2021年-2027年） Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial weakness. Some other symptoms include loss of taste, hyperacusis, and decreased salivation and tear secretion. The North American facial paralysis market is a gr…
世界のフェイシャルリンクルトリートメント市場規模・現状・予測（2021年-2027年） Facial wrinkle treatment involves procedures and medication intentional to delay, stop or retard the aging process. The rising geriatric population having age between 35-45 is the primary factor driving the growth of facial wrinkle treatment market. Market Analysis and Insights: Global Facial Wrinkl…